|
1) |
Stock RG, Cahlon O, Cesaretti AJ. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59(5):1352-9. |
2) |
Ghaly M, Wallner K, Merrick. The effect of supplemental beam radiation on prostate brachytherapy-related morbidity:morbidity outcomes from two prospective randomized multicenter trials. Int J Radiat Oncol Biol Phys. 2003;55(5):1288-93. |
3) |
Dattoli M, Wallner K, True L. Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;45(4);853-6. |